Akanda (AKAN) Stock Price, News & Analysis

Company Overview

Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products to patients worldwide. It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.

Key Stats

• Today's Range: $1.45 to $1.45
• 50-Day Range: $1.32 to $2.20
• 52-Week Range: $1.22 to $56.80
• Volume: 883 shs
• Average Volume: 346,224 shs
• Market Capitalization: $2.07 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

AKAN Stock Analysis - Frequently Asked Questions

How have AKAN shares performed this year?

Akanda's stock was trading at $35.24 at the beginning of 2024. Since then, AKAN stock has decreased by 95.6% and is now trading at $1.54.
View the best growth stocks for 2024 here.

When did Akanda's stock split?

Akanda shares reverse split on the morning of Thursday, May 23rd 2024. The 1-40 reverse split was announced on Thursday, May 23rd 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, May 23rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

When did Akanda IPO?

Akanda (AKAN) raised $16 million in an IPO on Tuesday, March 15th 2022. The company issued 4,000,000 shares at $4.00 per share.

How do I buy shares of Akanda?

Shares of AKAN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Akanda own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Akanda investors own include Pacific Biosciences of California (PACB), Tilray (TLRY), Recursion Pharmaceuticals (RXRX), Editas Medicine (EDIT), SoundHound AI (SOUN), Mobile-health Network Solutions (MNDR) and Ginkgo Bioworks (DNA).

Company Calendar

• Today: 12/27/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Medicinals & botanicals
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:AKAN
• CUSIP: N/A
• CIK: 1888014
• Web: www.akandacorp.com
• Phone: 44-20-3488-9514
• Fax: N/A
• Employees: 110
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.41
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $2.51 million
• Price / Sales: 0.88
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($76.10) per share
• Price / Book: -0.02

Miscellaneous

• Outstanding Shares: 1,427,000
• Free Float: 1,136,000
• Market Cap: $2.20 million
• Optionable: Not Optionable
• Beta: 1.69